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n malaria-endemic countries of 
Africa, anaemia is very common in 
pregnant women and in children 
under ﬁ  ve. Although anaemia is 
multifactorial—causative factors 
include iron deﬁ  ciency and other 
nutritional deﬁ  ciencies, helminth 
infection, and HIV—malaria is clearly 
an extremely important factor. 
Over half of malaria-related deaths 
are attributed to severe malaria 
anaemia (which is deﬁ  ned as malaria 
parasitaemia and a haemoglobin 
(Hb) concentration less than 
50 g/l) [1]. Several antimalarial 
interventions have been shown to 
prevent anaemia, including insecticide-
treated nets, residual spraying, 
malaria chemoprophylaxis, and, more 
recently, intermittent presumptive 
treatment of infants (i. e., antimalarials 
coadministered with childhood 
immunization). Insecticide-treated nets 
have been shown to decrease all-cause 
mortality [2].
    The pathogenesis of malaria 
anaemia remains incompletely 
understood. Dyserythropoiesis 
(disordered red cell development, 
which is, at least in part, due to 
inﬂ  ammatory cytokines acting on 
erythroid precursors), intravascular 
haemolysis of infected red cells, and 
destruction of both parasitized and 
uninfected erythrocytes by splenic 
macrophages are all important 
[3,4]. Interestingly, it has been 
estimated that ten or more uninfected 
erythrocytes may be lost for each 
infected one [5], presumably because 
malaria infection alters uninfected 
erythrocytes. The probable causes 
of red cell loss include oxidation of 
band 3 (the anion transporter of the 
erythrocyte membrane) or membrane 
lipids, and deposition of IgG, 
complement, or immune complexes 
on the erythrocyte surface.
    The Possible Role of Haptoglobin 
in Malaria Anaemia
    The glycoprotein haptoglobin (Hp) 
is the body’s main tool for removing 
circulating, toxic free Hb during 
intravascular haemolysis. Hp binds 
rapidly and with high afﬁ  nity to free 
Hb, with the resultant complex being 
taken up by CD163, which is expressed 
on monocytes/macrophage lineage 
cells. Binding of Hp/Hb complexes 
to CD163 leads to cytokine secretion 
by macrophages [6]. In the absence 
of Hp, free Hb can enter and damage 
renal glomeruli, and is a potent oxidant 
that can lead to the generation of 
reactive oxygen species. 
    In humans, unlike other animals, 
Hp exists in two forms. The   Hp2  gene 
arose by duplication of a region of 
the gene encoding the α chain of   Hp1 , 
leading to three phenotypes—1-1, 
2-1, and 2-2. Hp1-1 leads to smaller, 
more abundant dimers with a higher 
afﬁ  nity for Hb, and to Hp/Hb 
complexes with a lower afﬁ  nity for 
CD163. Studies have associated the 
Hp2-2 phenotype with increased 
morbidity from cardiovascular 
disease, diabetes, HIV infection, and 
other conditions—perhaps because 
concentrations of Hp2-2 are lower, 
Hp2-2 is less able than Hp1-1 to 
penetrate extravascular spaces, and 
Hp2-2 is less able to prevent oxidative 
damage or immune activation than the 
other phenotypes [7].
    Given the importance of 
intravascular haemolysis in malaria 
infection, studies of Hp in malaria are 
important, but results to date have 
been inconclusive. Earlier studies 
based on phenotyping suggested 
Hp1-1 was associated with severe or 
symptomatic infection [8,9]. For 
example, in one study of 72 patients 
in Sudan with cerebral malaria, 
the percentage of patients with Hp 
phenotypes 1-1, 2-1, and 2-2 were 
63.9%, 29.2%, and 6.9%, respectively 
[8]. But the low prevalence of 
Hp2-2 and the high prevalence of 
Hp1-1 in the patients in this study 
may reﬂ  ect lack of sensitivity of the 
electrophoretic technique used in 
the study to detect the less abundant 
(and multiple) bands of Hp2-2 rather 
than the single abundant Hp1-1. 
Circulating levels of Hp1-1 are 
normally signiﬁ  cantly higher than 
those of Hp2-2, but levels fall during 
malaria infection due to clearance of 
Hp/Hb complexes; age may inﬂ  uence 
the degree of fall in Hp with malaria 
[10]. More recently, PCR-based 
genotyping studies have examined 
associations between   Hp   genotype 
and severe malaria or associations 
between   Hp   genotype and mild disease 
[11,12]. These studies did not ﬁ  nd 
clear associations with   Hp   genotype; 
although, in one study, there was 
a suggestion of an association with 
severe malaria, especially severe 
anaemia. 
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  A  New  Study
    In a new study in   PLoS Medicine  , 
Atkinson and colleagues have taken 
a different approach [13]. Working 
in The Gambia, where malaria 
transmission is intense but highly 
seasonal and anaemia is a common 
complication, they followed a group of 
children over the malaria season. The 
authors used Hb concentration as their 
main readout. Although baseline Hb 
levels were similar across   Hp   genotypes, 
children who were   Hp2/2  had a greater 
fall in Hb (by 4 g/l) over the malaria 
season than did other children.   Hp   
genotype signiﬁ  cantly predicted Hb 
levels at the end of the malaria season 
in multivariate analysis, together with 
iron status and several other variables. 
A separate analysis examining factors 
inﬂ  uencing the magnitude of the fall 
in Hb gave similar results. Additionally, 
children with   Hp2/2  genotype were more 
likely to be parasitaemic. The authors 
suggest that the effect of   Hp   genotype 
on the fall in Hb (and, thus, possible 
protection from anaemia) may be 
more signiﬁ  cant than that of sickle cell 
trait (HbAS) or glucose-6-phosphate 
dehydrogenase deﬁ  ciency. On the 
other hand, sickle cell trait and glucose-
6-phosphate dehydrogenase deﬁ  ciency 
have been more compellingly 
associated with protection from severe 
malaria than have   Hp   genotypes [14]. 
    How Does Hp Affect Hb Levels?
    How does   Hp   genotype inﬂ  uence 
Hb fall? The authors offer several 
interesting suggestions. Because 
destruction of uninfected erythrocytes 
may be especially important in 
development of malaria anaemia, this 
mechanism is one plausible route. 
Oxidative damage to uninfected cells 
might be more marked in Hp2-2
 individuals since Hp2-2 proteins 
bind less efﬁ  ciently to Hb, and since 
levels of Hp2-2 are lower and more 
easily depleted, increasing premature 
destruction of erythrocytes. Another 
reason   Hp   genotype may inﬂ  uence Hb 
levels might be because complexes of 
Hp2-2 with Hb, but not other Hp/Hb 
complexes, enter monocytes (which 
express less CD163 than macrophages), 
stimulating cytokine release by these 
circulating cells. Thus, different Hp 
types inducing different cytokine 
responses may affect the duration of 
inﬂ  ammatory, marrow-suppressive 
cytokine production following malaria. 
Persistent marrow suppression, 
as judged by inappropriately low 
reticulocyte responses after resolution 
of infection, is a feature of malaria 
[3,4]. And   Hp2/2  genotype has been 
associated with increased iron 
accumulation in haemochromatosis—
in one study but not in others 
(reviewed in [7])—suggesting   Hp   
genotype may have some role in iron 
homeostasis. Interestingly, the 17% 
prevalence of   Hp2/2  in Atkinson and 
colleagues’ study was much lower than 
that which was reported in European 
populations [7], suggesting a possible 
protective role for   Hp1  genotypes 
against malaria. 
  Public  Health  Implications
    Is a 4 g/l difference in Hb fall clinically 
relevant? Probably. Although the 
effects of this fall on the proportion of 
children suffering moderate or severe 
anaemia are not given in the study, the 
population distribution of Hb levels is 
wide. A fall in mean Hb may translate 
into increased numbers of individuals 
with symptomatic disease, although 
this effect is not demonstrated in this 
study. From a public health perspective, 
interventions that result in a rise in 
Hb of similar magnitude—such as 
intermittent presumptive treatment 
in pregnancy [15]—are endorsed by 
the World Health Organization. And 
small changes in group levels may 
hide subgroups with more dramatic 
changes in Hb. How one might 
identify individuals at risk for the 
more dramatic falls in Hb, or whether 
antimalarial measures would prevent 
such falls, are unresolved questions.   
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